Cargando…
The gastrointestinal and microbiome impact of a resistant starch blend from potato, banana, and apple fibers: A randomized clinical trial using smart caps
The gastrointestinal (GI) impact of fibers including resistant starch (RS) consumption depends on various types and amounts of fibers, the initial microbiome states, and accurate intake measurements. A randomized clinical trial evaluated the GI impact of varying doses of a novel resistant starch ble...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559413/ https://www.ncbi.nlm.nih.gov/pubmed/36245486 http://dx.doi.org/10.3389/fnut.2022.987216 |
_version_ | 1784807643944058880 |
---|---|
author | Hanes, Douglas Nowinski, Brent Lamb, Joseph J. Larson, Ilona A. McDonald, Daniel Knight, Rob Song, Se Jin Patno, Noelle |
author_facet | Hanes, Douglas Nowinski, Brent Lamb, Joseph J. Larson, Ilona A. McDonald, Daniel Knight, Rob Song, Se Jin Patno, Noelle |
author_sort | Hanes, Douglas |
collection | PubMed |
description | The gastrointestinal (GI) impact of fibers including resistant starch (RS) consumption depends on various types and amounts of fibers, the initial microbiome states, and accurate intake measurements. A randomized clinical trial evaluated the GI impact of varying doses of a novel resistant starch blend (RSB) with smart cap monitoring. RSB contained at least 50% RS and was a proprietary mixture of a potato starch, green banana flour, and apple fiber powder (a source of apple pectin, not resistant starch). The study design randomized participants to one of four arms: 10 g/day of potato starch (0 RSB), 10 g/day of RSB, 10 to 20 to 20 g/day of RSB or 10 to 20 to 30 g/day RSB for two-week intervals over 6 weeks. Results confirmed that while resistant starch of approximately 5 g per day improves GI symptoms at 2, 4, and 6 weeks, it did not demonstrate a detectable effect on short chain fatty acids. Increasing doses of the blend (RSB) led to a decrease in the diarrhea score. Using an estimate of total consumption of RSB based on smart cap recordings of container openings and protocol-specified doses of RSB, a reduction in the sleep disturbance score was associated with higher RSB dose. The exploratory microbiome evaluation demonstrated that among the 16S rRNA gene sequences most associated with the consumption of the novel blend RSB, two belong to taxa of notable interest to human health: Faecalibacterium and Akkermansia. |
format | Online Article Text |
id | pubmed-9559413 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95594132022-10-14 The gastrointestinal and microbiome impact of a resistant starch blend from potato, banana, and apple fibers: A randomized clinical trial using smart caps Hanes, Douglas Nowinski, Brent Lamb, Joseph J. Larson, Ilona A. McDonald, Daniel Knight, Rob Song, Se Jin Patno, Noelle Front Nutr Nutrition The gastrointestinal (GI) impact of fibers including resistant starch (RS) consumption depends on various types and amounts of fibers, the initial microbiome states, and accurate intake measurements. A randomized clinical trial evaluated the GI impact of varying doses of a novel resistant starch blend (RSB) with smart cap monitoring. RSB contained at least 50% RS and was a proprietary mixture of a potato starch, green banana flour, and apple fiber powder (a source of apple pectin, not resistant starch). The study design randomized participants to one of four arms: 10 g/day of potato starch (0 RSB), 10 g/day of RSB, 10 to 20 to 20 g/day of RSB or 10 to 20 to 30 g/day RSB for two-week intervals over 6 weeks. Results confirmed that while resistant starch of approximately 5 g per day improves GI symptoms at 2, 4, and 6 weeks, it did not demonstrate a detectable effect on short chain fatty acids. Increasing doses of the blend (RSB) led to a decrease in the diarrhea score. Using an estimate of total consumption of RSB based on smart cap recordings of container openings and protocol-specified doses of RSB, a reduction in the sleep disturbance score was associated with higher RSB dose. The exploratory microbiome evaluation demonstrated that among the 16S rRNA gene sequences most associated with the consumption of the novel blend RSB, two belong to taxa of notable interest to human health: Faecalibacterium and Akkermansia. Frontiers Media S.A. 2022-09-29 /pmc/articles/PMC9559413/ /pubmed/36245486 http://dx.doi.org/10.3389/fnut.2022.987216 Text en Copyright © 2022 Hanes, Nowinski, Lamb, Larson, McDonald, Knight, Song and Patno. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Nutrition Hanes, Douglas Nowinski, Brent Lamb, Joseph J. Larson, Ilona A. McDonald, Daniel Knight, Rob Song, Se Jin Patno, Noelle The gastrointestinal and microbiome impact of a resistant starch blend from potato, banana, and apple fibers: A randomized clinical trial using smart caps |
title | The gastrointestinal and microbiome impact of a resistant starch blend from potato, banana, and apple fibers: A randomized clinical trial using smart caps |
title_full | The gastrointestinal and microbiome impact of a resistant starch blend from potato, banana, and apple fibers: A randomized clinical trial using smart caps |
title_fullStr | The gastrointestinal and microbiome impact of a resistant starch blend from potato, banana, and apple fibers: A randomized clinical trial using smart caps |
title_full_unstemmed | The gastrointestinal and microbiome impact of a resistant starch blend from potato, banana, and apple fibers: A randomized clinical trial using smart caps |
title_short | The gastrointestinal and microbiome impact of a resistant starch blend from potato, banana, and apple fibers: A randomized clinical trial using smart caps |
title_sort | gastrointestinal and microbiome impact of a resistant starch blend from potato, banana, and apple fibers: a randomized clinical trial using smart caps |
topic | Nutrition |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559413/ https://www.ncbi.nlm.nih.gov/pubmed/36245486 http://dx.doi.org/10.3389/fnut.2022.987216 |
work_keys_str_mv | AT hanesdouglas thegastrointestinalandmicrobiomeimpactofaresistantstarchblendfrompotatobananaandapplefibersarandomizedclinicaltrialusingsmartcaps AT nowinskibrent thegastrointestinalandmicrobiomeimpactofaresistantstarchblendfrompotatobananaandapplefibersarandomizedclinicaltrialusingsmartcaps AT lambjosephj thegastrointestinalandmicrobiomeimpactofaresistantstarchblendfrompotatobananaandapplefibersarandomizedclinicaltrialusingsmartcaps AT larsonilonaa thegastrointestinalandmicrobiomeimpactofaresistantstarchblendfrompotatobananaandapplefibersarandomizedclinicaltrialusingsmartcaps AT mcdonalddaniel thegastrointestinalandmicrobiomeimpactofaresistantstarchblendfrompotatobananaandapplefibersarandomizedclinicaltrialusingsmartcaps AT knightrob thegastrointestinalandmicrobiomeimpactofaresistantstarchblendfrompotatobananaandapplefibersarandomizedclinicaltrialusingsmartcaps AT songsejin thegastrointestinalandmicrobiomeimpactofaresistantstarchblendfrompotatobananaandapplefibersarandomizedclinicaltrialusingsmartcaps AT patnonoelle thegastrointestinalandmicrobiomeimpactofaresistantstarchblendfrompotatobananaandapplefibersarandomizedclinicaltrialusingsmartcaps AT hanesdouglas gastrointestinalandmicrobiomeimpactofaresistantstarchblendfrompotatobananaandapplefibersarandomizedclinicaltrialusingsmartcaps AT nowinskibrent gastrointestinalandmicrobiomeimpactofaresistantstarchblendfrompotatobananaandapplefibersarandomizedclinicaltrialusingsmartcaps AT lambjosephj gastrointestinalandmicrobiomeimpactofaresistantstarchblendfrompotatobananaandapplefibersarandomizedclinicaltrialusingsmartcaps AT larsonilonaa gastrointestinalandmicrobiomeimpactofaresistantstarchblendfrompotatobananaandapplefibersarandomizedclinicaltrialusingsmartcaps AT mcdonalddaniel gastrointestinalandmicrobiomeimpactofaresistantstarchblendfrompotatobananaandapplefibersarandomizedclinicaltrialusingsmartcaps AT knightrob gastrointestinalandmicrobiomeimpactofaresistantstarchblendfrompotatobananaandapplefibersarandomizedclinicaltrialusingsmartcaps AT songsejin gastrointestinalandmicrobiomeimpactofaresistantstarchblendfrompotatobananaandapplefibersarandomizedclinicaltrialusingsmartcaps AT patnonoelle gastrointestinalandmicrobiomeimpactofaresistantstarchblendfrompotatobananaandapplefibersarandomizedclinicaltrialusingsmartcaps |